Andreas Leiherer

Head

Vorarlberg Institute for Vascular Investigation and Treatment

Austria

Research Interests

Explore related searches

Professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Andreas Leiherer is the Head at the Vorarlberg Institute for Vascular Investigation and Treatment in Austria. His research areas include cardiovascular health, the use of machine learning in bioinformatics, and the impact of inflammatory markers on COVID-19 outcomes. Recent articles authored by him explore topics such as lipid-lowering therapies, diabetes risk prediction, and vaccination effects in older adults. His work contributes significantly to understanding the interplay between metabolic factors and vascular health.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (2)

Wolfgang Hitzl

Paracelsus Medizinische Privatuniversität

AUSTRIA

View details

Heinz Drexel

Drexel University College of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andreas Leiherer

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Evaluation of Circulating Glypican-4 in Patients with ESKD

25 years of lipid-lowering therapy: secular trends in therapy of coronary patients

Anti-SARS-CoV-2 Antibodies versus Vaccination Status in CAD Patients with COVID-19: A Prospective, Propensity Score-Matched Cohort Study

Current Practices of Medication Plans in Austrian Patients Undergoing Coronary Angiography: An In-Depth Analysis

Machine Learning Approach to Metabolomic Data Predicts Type 2 Diabetes Mellitus Incidence

Special Issue “Machine Learning and Bioinformatics in Human Health and Disease”—Chances and Challenges

Antibody levels versus vaccination status in the outcome of older adults with COVID-19

Interplay of inflammatory markers and anti-SARS-CoV-2 antibodies in COVID-19 mortality: A prospective cohort study

The value of earlier-in-life systolic and diastolic blood pressure for cardiovascular risk prediction

Ceramides improve cardiovascular risk prediction beyond low-density lipoprotein cholesterol

Collaborators (2)

Wolfgang Hitzl

Heinz Drexel

Make your next move.